Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded
- Contract number
- SPE2DB25FX7Z0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,827
Award facts
- Contract value 100% obligated
- $26,827.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,827.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of delivery orders for branded and generic prescription drugs, biologics, and medical consumables primarily to the Department of Defense. The company's federal contracting history demonstrates consistent success in competing for pharmaceutical supply contracts without set-aside designations, leveraging its woman-owned small business status. Trikafta, a cystic fibrosis therapeutic, represents the type of specialty pharmaceutical product within the company's core distribution capabilities to military and federal healthcare facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FX7Z0?
SPE2DB25FX7Z0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FX7Z0 worth?
The government has obligated $26,827 on SPE2DB25FX7Z0.
Is contract SPE2DB25FX7Z0 an order under another contract?
Yes. SPE2DB25FX7Z0 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX7Z0 competed?
The extent of competition for SPE2DB25FX7Z0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award